/cloudfront-us-east-2.images.arcpublishing.com/reuters/CCBS56SBRRKUDM7JEVVE3UOQEE.jpg "Teva halts output at U.S. drug plant after FDA flags concerns | Reuters")
Teva halts output at U.S. drug plant after FDA flags concerns | Reuters
FDA approves Teva's generic EpiPen after yearslong delay
Teva continues to wobble as rival drug receives FDA approval - Israel News - The Jerusalem Post
TEVA PHARMACEUTICAL INDUSTRIES LTD: Teva Announces FDA Approval of AirDuo® Digihaler™ (fluticasone propionate 113 mcg and salmeterol 14 mcg) Inhalation Powder | FDA Health News
Teva refiles long-acting schizophrenia drug after FDA rejection
Health News Roundup: U.S. FDA warns of ADHD drug Adderall shortage on Teva manufacturing delays; Child malnutrition soars in central Somalia area on verge of famine and more | Health
Regeneron and Teva's fasinumab hit with FDA clinical hold | Fierce Biotech
Teva Wins FDA Approval for First Viagra Generic, Will Not Launch Until 2017 | RAPS
Teva Earns First FDA Approval for Generic Drug for Major Depressive Disorder | 2019-10-10 | FDAnews
TEVA: Announces FDA Approval of AJOVY® (fremanezumab-vfrm) Injection Autoinjector | FDA Health News
Catalyst Pharma Shares Take A Hit As Teva Files For Generic Version Of Its Lead Product
UPDATE 1-U.S. FDA warns of ADHD drug Adderall shortage on Teva manufacturing delays
Teva's pursuit of J&J boosted by FDA acceptance of filing for approval of long-acting schizophrenia drug | Fierce Pharma
Catalyst stock slumps ~20% as Teva seeks FDA approval of generic Firdapse | Seeking Alpha
Teva's troubled Godollo plant earns firm US FDA warning letter
Troubled Teva plant in Hungary faces an FDA crackdown - STAT
U.S. FDA warns of ADHD drug Adderall shortage on Teva manufacturing delays, Health News, ET HealthWorld
Mylan's fight against Teva highlights logjam created by FDA petitions | Modern Healthcare
Teva recalls US-made drugs following contamination fears - The Boston Globe
Teva, chasing Amgen's Aimovig, scores much-needed FDA approval for migraine drug Ajovy | Fierce Pharma
FDA Rejects Teva's Application For Huntington's Drug - WSJ
FDA accepts Teva-MedinCell's new drug application for schizophrenia drug
Teva Issues Voluntary Nationwide Recall of One Lot of Anagrelide Capsules | DAIC
FDA declines to approve Teva-MedinCell's risperidone injection for treating schizophrenia | Seeking Alpha
